Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.33 per share a year ago.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
MD expands maternal care in Tennessee through a new partnership, boosts high-risk pregnancy services and aims for immediate earnings accretion.
Favorable payer mix, higher neonatology acuity and prudent acquisitions will support MD's growth, while shares look undervalued versus industry peers.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MD's Q4 EPS miss estimates as revenues dip, but same-unit gains and a stronger 2026 EBITDA outlook signal mixed momentum.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago.
MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.